Brown Capital Management’s RxSight RXST Stock Holding History

Brown Capital Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Sell	216,300 -32,596	-13%	-$197K	0.21%	51
2026 Q1	$1.53M	Sell	248,896 -108,817	-30%	-$904K	0.22%	53
2025 Q4	$3.73M	Sell	357,713 -413,467	-54%	-$4.15M	0.31%	50
2025 Q3	$6.93M	Sell	771,180 -348,060	-31%	-$3.05M	0.29%	48
2025 Q2	$14.6M	Buy	1,119,240 +171,952	+18%	+$2.59M	0.42%	45
2025 Q1	$23.9M	Buy	947,288 +105,096	+12%	+$3.12M	0.72%	43
2024 Q4	$29M	Buy	842,192 +299,755	+55%	+$13.5M	0.67%	40
2024 Q3	$26.8M	Buy	+542,437	New	+$27.8M	0.58%	41

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Brown Capital Management's RXST Position: Q2 2026 in Review

Brown Capital Management reduced its RxSight (RXST) stake by 13% in Q2 2026, selling an estimated $197K and leaving 216,300 shares worth $1.04M. The position accounts for 0.21% of the portfolio, ranked #51.

Brown Capital Management first reported a position in RXST in Q3 2024 and has held it in 8 quarters since. The position peaked at $29M in Q4 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Brown Capital Management held 216,300 shares of RxSight worth $1.04M as of Q2 2026.
Brown Capital Management sold 32,596 RxSight shares in Q2 2026, an estimated $197K.
RxSight made up 0.21% of Brown Capital Management's portfolio in Q2 2026, its #51 holding.
Brown Capital Management first reported a position in RxSight in Q3 2024 and has held it in 8 quarters since.
Brown Capital Management's RxSight position peaked at $29M in Q4 2024.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Brown Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.